ARCHIVES

Tarceva-Induced Rash Strongly Associated With Longer Survival, Sponsor Finds

This article is from The Cancer Letter archive.

Vol. 30 No. 7 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Bypass Budget Seeks $1 Billion Increase For FY 2011

February 26, 2010

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

May 28, 2004

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

November 1, 1985

In Brief: Henney To Leave NCI For Kansas; Dan Longo Heads BRMP; DeVita To Receive Nervi Award

May 10, 1985

In Brief: NCI Terminates Straus’ Grant Following Site Visit Report Charging “Lack Of satisfactory Progress

February 19, 1982

DCT Board Delays Action On Protein Index, Refuses Support for Cow Study, Approves Various Concepts

October 16, 1981